Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:10 pm Sale |
2024-09-30 | 13G | GeoVax Labs, Inc. GOVX |
ARMISTICE CAPITAL LLC | 946,137 9.990% |
-2,164,932 (-69.59%) |
Filing History |
| 2024-11-14 5:08 pm Purchase |
2024-09-30 | 13G | Eyenovia, Inc. EYEN |
ARMISTICE CAPITAL LLC | 107,500 9.950% |
52,775 (+96.44%) |
Filing History |
| 2024-11-14 5:07 pm Purchase |
2024-09-30 | 13G | Dermata Therapeutics, Inc. DRMA |
ARMISTICE CAPITAL LLC | 186,211 9.990% |
186,211 (New Position) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
ARMISTICE CAPITAL LLC | 1,313,348 9.990% |
234,889 (+21.78%) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | BIO-key International, Inc. BKYI |
ARMISTICE CAPITAL LLC | 250,000 8.950% |
128,506 (+105.77%) |
Filing History |
| 2024-11-14 5:03 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
ARMISTICE CAPITAL LLC | 319,756 9.990% |
319,756 (New Position) |
Filing History |
| 2024-11-14 5:01 pm Purchase |
2024-09-30 | 13G | Worksport Ltd. WKSP |
ARMISTICE CAPITAL LLC | 309,777 9.990% |
103,188 (+49.95%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | T Stamp Inc. IDAI |
ARMISTICE CAPITAL LLC | 134,886 9.990% |
72,406 (+115.89%) |
Filing History |
| 2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
ARMISTICE CAPITAL LLC | 272,000 6.770% |
-118,560 (-30.36%) |
Filing History |
| 2024-11-14 4:51 pm Sale |
2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
ARMISTICE CAPITAL LLC | 2,364,000 5.960% |
-78,742 (-3.22%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Cosmos Health Inc. COSM |
ARMISTICE CAPITAL LLC | 2,148,188 9.990% |
644,077 (+42.82%) |
Filing History |
| 2024-11-14 4:49 pm Purchase |
2024-09-30 | 13G | Vivos Therapeutics, Inc. VVOS |
ARMISTICE CAPITAL LLC | 250,277 4.990% |
75,178 (+42.93%) |
Filing History |
| 2024-11-14 4:49 pm Purchase |
2024-09-30 | 13G | Checkpoint Therapeutics, Inc. CKPT |
ARMISTICE CAPITAL LLC | 4,573,746 9.990% |
1,858,111 (+68.42%) |
Filing History |
| 2024-11-14 4:48 pm Purchase |
2024-09-30 | 13G | Can-Fite BioPharma Ltd. CANF |
ARMISTICE CAPITAL LLC | 678,530 9.990% |
24,584 (+3.76%) |
Filing History |
| 2024-11-14 4:47 pm Sale |
2024-09-30 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
ARMISTICE CAPITAL LLC | 8,200,000 5.730% |
-1,336,000 (-14.01%) |
Filing History |
| 2024-11-14 4:46 pm Purchase |
2024-09-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ARMISTICE CAPITAL LLC | 5,096,251 10.820% |
470,061 (+10.16%) |
Filing History |
| 2024-11-14 4:46 pm Sale |
2024-09-30 | 13G | Virax Biolabs Group Limited VRAX |
ARMISTICE CAPITAL LLC | 228,042 4.990% |
-2,103 (-0.91%) |
Filing History |
| 2024-11-14 4:43 pm Sale |
2024-09-30 | 13G | Allurion Technologies Inc. ALUR |
ARMISTICE CAPITAL LLC | 312,240 12.130% |
-10,880 (-3.37%) |
Filing History |
| 2024-11-14 4:43 pm Purchase |
2024-09-30 | 13G | Trevena, Inc. TRVN |
ARMISTICE CAPITAL LLC | 44,796 4.990% |
44,796 (New Position) |
Filing History |
| 2024-11-14 4:42 pm Purchase |
2024-09-30 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP |
ARMISTICE CAPITAL LLC | 15,001 0.830% |
15,001 (New Position) |
Filing History |